» Articles » PMID: 24504733

Deficiency of ATP-binding Cassette Transporter B6 in Megakaryocyte Progenitors Accelerates Atherosclerosis in Mice

Overview
Date 2014 Feb 8
PMID 24504733
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The ATP-binding cassette (ABC) transporter B6 (ABCB6) is highly expressed in megakaryocyte progenitors, but its role in platelet production and disease has not been elucidated.

Approach And Results: Among various ABC transporters, ABCB6 was highly expressed in megakaryocyte progenitors, exhibiting the same pattern of expression of genes involved in heme synthesis pathway. Transplantation of Abcb6 deficient (Abcb6(-/-)) bone marrow into low density lipoprotein receptor deficient recipient mice resulted in expansion and proliferation of megakaryocyte progenitors, attributable to increased reactive oxygen species production in response to porphyrin loading. The enhanced megakaryopoiesis in Abcb6(-/-) bone marrow-transplanted mice was further illustrated by increased platelet counts, mean platelet volume, and platelet activity. Platelets from Abcb6(-/-) bone marrow-transplanted mice had higher levels of chemokine (C-C motif) ligand 5, which was associated with increased plasma chemokine (C-C motif) ligand 5 levels. There were also increased platelet-leukocyte aggregates, which resulted in leukocyte activation. Abcb6(-/-) bone marrow-transplanted mice had accelerated atherosclerosis which was associated with deposition of the chemotactic agent, chemokine (C-C motif) ligand 5 in atherosclerotic plaques, resulting in increased macrophage accumulation.

Conclusions: Our findings identify a new role of ABCB6 in preventing atherosclerosis development by dampening platelet production, reactivity, and chemokine (C-C motif) ligand 5 deposition in atherosclerotic lesions.

Citing Articles

Haematometabolism rewiring in atherosclerotic cardiovascular disease.

Yvan-Charvet L, Barouillet T, Borowczyk C Nat Rev Cardiol. 2025; .

PMID: 39743562 DOI: 10.1038/s41569-024-01108-9.


Nrf2-mediated ferroptosis inhibition: a novel approach for managing inflammatory diseases.

Han H, Zhang G, Zhang X, Zhao Q Inflammopharmacology. 2024; 32(5):2961-2986.

PMID: 39126567 DOI: 10.1007/s10787-024-01519-7.


Top Five Stories of the Cellular Landscape and Therapies of Atherosclerosis: Current Knowledge and Future Perspectives.

Pan Q, Chen C, Yang Y Curr Med Sci. 2023; 44(1):1-27.

PMID: 38057537 DOI: 10.1007/s11596-023-2818-2.


W546 stacking disruption traps the human porphyrin transporter ABCB6 in an outward-facing transient state.

Lee S, Park J, Jang E, Choi S, Kim S, Kim J Commun Biol. 2023; 6(1):960.

PMID: 37735522 PMC: 10514269. DOI: 10.1038/s42003-023-05339-3.


Identification of immune infiltration and cuproptosis-related subgroups in Crohn's disease.

Yuan Y, Fu M, Li N, Ye M Front Immunol. 2022; 13:1074271.

PMID: 36466876 PMC: 9713932. DOI: 10.3389/fimmu.2022.1074271.